Skip to content

ALPS.MY

ALPS Group, Inc.

Healthcare · Biotechnology · MY

Ask drillr

Income statement

MetricTTM2026202520242022
Revenue
Total Revenue4.9M3.4M2.4M3.6M
Cost of Revenue3.3M2.1M1.8M1.6M
Gross Profit1.6M1.3M598.9K2.0M
Operating Expenses
R&D Expense
SG&A Expense1.3M3.7M2.7M2.1M26.1M
General & Admin Expense3.5M2.4M1.9M26.1M
Selling & Marketing Expense205.6K273.5K160.9K
Other Expenses535.3K1.2M1.1M917.5K(23.6M)
Total Operating Expenses1.8M4.9M3.8M3.0M2.5M
Cost and Expenses1.8M8.2M5.9M4.8M4.1M
Operating Income (EBIT)(1.8M)(3.4M)(2.5M)(2.4M)(535.5K)
Non-Operating
Interest Income96.9K3.9K123.00
Interest Expense1.7M50.5K48.3K42.8K46.6K
Net Interest Income(1.6M)(46.6K)(48.2K)(42.8K)(46.6K)
Other Non-Op Income/Expense(1.6M)1.3M(27.6K)10.6K(46.6K)
Non-Operating Income (excl Interest)(48.5K)1.3M20.5K53.4K
EBT (Pre-Tax Income)(3.4M)(2.1M)(2.5M)(2.4M)(582.1K)
Income Tax Expense5.1K95.6K(7.4K)147.8K
Bottom Line
Net Income(3.4M)(2.0M)(2.5M)(2.3M)(729.2K)
Earnings from Cont. Ops(3.4M)(2.1M)(2.6M)(2.4M)(729.9K)
Earnings from Discont. Ops
Bottom Line Net Income(3.4M)(2.0M)(2.5M)(2.3M)(729.2K)
Per Share
Basic EPS($0.96)($0.02)($0.02)($0.01)($0.02)
Diluted EPS($0.96)($0.02)($0.02)($0.01)($0.00)
Revenue Per Share$0.00$0.03$0.02$0.02$0.10
Shares
Basic Shares Outstanding3.5M162.4M160.0M160.0M34.5M
Diluted Shares Outstanding3.5M162.4M160.0M160.0M53.6M
Profitability Metrics
EBITDA(1.8M)(901.4K)(1.4M)(1.5M)363.2K
D&A1.1M1.1M903.4K898.6K
EBIT(1.8M)(2.0M)(2.5M)(2.4M)(535.5K)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026